Clinical Trial: Flubendazole Added to Standard Concurrent Chemoradiotherapy With Temozolomide in Patients With High-Grade Glioma

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847476) titled 'Flubendazole Added to Standard Concurrent Chemoradiotherapy With Temozolomide in Patients With High-Grade Glioma' on Sept. 16.

Brief Summary: This study To evalute the efficacy and safety of adding flubendazole to standard concurrent chemoradiotherapy with temozolomide in patients with high grade glioma and also to evaluate DFS,OS for those patients in clinical oncology department , Assiut university Hospital .

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Glioma Patients

Intervention: DRUG: Flubendazole

Flubendazole 100 mg twice daily for 3 day in the week for 6 weeks

Recruitment Status: NOT_YET_RECRUITIN...